Showing results (211-220 of 369) with videos related to

Sort By:
Pageof 37
European Journal of Cancer (Oxford, England : 1990)|March 3, 2022
Characteristics of clinical trials for haematological malignancies from 2015 to 2020: A systematic reviewWilliam Wesson, Vincent L Galate, Douglas W Sborov, et al.
Ecancermedicalscience|August 7, 2018
A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot studyKazunori Honda, Bishal Gyawali, Masashi Ando, et al.
Clinical Genitourinary Cancer|April 14, 2021
Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease Control in Patients With Metastatic Urothelial Carcinoma treated With ImmunotherapyFrancesco Rundo, Melissa Bersanelli, Valeria Urzia, et al.
Tumori|April 25, 2015
Inferior mesenteric artery chemoembolization and chemotherapy for advanced rectal cancer: report of a clinical caseRoberto Bini, Simone Comelli, Alfredo Addeo, et al.
Gynecologic Oncology Reports|July 3, 2020
Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutationJulie Terzic, Amanda Seipel, Jean Dubuisson, et al.
The Oncologist|September 23, 2023
Breast Cancer-Related Financial Toxicity in Sri Lanka: Insights From a Lower Middle-Income Country With Free Universal Public HealthcareSarith Ranawaka, Sathika Gunarathna, Sanjeeva Gunasekera, et al.
JCO Global Oncology|May 27, 2022
Colorectal Cancer Treatment Characteristics and Concordance With Guidelines in Sri Lanka: Results From a Hospital-Based Cancer RegistryDon Thiwanka Wijeratne, Sanjeeva Gunasekara, Christopher M Booth, et al.
Ecancermedicalscience|June 23, 2021
Differences in cancer incidence and pattern between urban and rural Nepal: one-year experience from two population-based cancer registriesRanjeeta Subedi, Atul Budukh, Sandhya Chapagain, et al.
JAMA Internal Medicine|October 18, 2021
Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018Mengyuan Fu, Huseyin Naci, Christopher M Booth, et al.
Plos One|December 7, 2018
Correction: Awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of Nepal: Findings from a cross-sectional study conducted as a part of COBIN-D trialBishal Gyawali, Martin Rune Hassan Hansen, Mia Buhl Povlsen, et al.
Pageof 37